nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—Hirsutism—Alitretinoin—peripheral nervous system neoplasm	0.00587	0.00593	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Alitretinoin—peripheral nervous system neoplasm	0.00573	0.0058	CcSEcCtD
Fludrocortisone—Optic neuritis—Alitretinoin—peripheral nervous system neoplasm	0.00554	0.0056	CcSEcCtD
Fludrocortisone—Contusion—Tretinoin—peripheral nervous system neoplasm	0.00516	0.00521	CcSEcCtD
Fludrocortisone—Contusion—Isotretinoin—peripheral nervous system neoplasm	0.00516	0.00521	CcSEcCtD
Fludrocortisone—Amenorrhoea—Melphalan—peripheral nervous system neoplasm	0.00506	0.00511	CcSEcCtD
Fludrocortisone—Cataract—Tretinoin—peripheral nervous system neoplasm	0.00473	0.00478	CcSEcCtD
Fludrocortisone—Cataract—Isotretinoin—peripheral nervous system neoplasm	0.00473	0.00478	CcSEcCtD
Fludrocortisone—Optic neuritis—Cisplatin—peripheral nervous system neoplasm	0.00472	0.00477	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Alitretinoin—peripheral nervous system neoplasm	0.00461	0.00466	CcSEcCtD
Fludrocortisone—Optic neuritis—Etoposide—peripheral nervous system neoplasm	0.00433	0.00437	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Topotecan—peripheral nervous system neoplasm	0.00412	0.00417	CcSEcCtD
Fludrocortisone—Oesophagitis—Tretinoin—peripheral nervous system neoplasm	0.00411	0.00416	CcSEcCtD
Fludrocortisone—Oesophagitis—Isotretinoin—peripheral nervous system neoplasm	0.00411	0.00416	CcSEcCtD
Fludrocortisone—Neoplasm—Topotecan—peripheral nervous system neoplasm	0.0041	0.00415	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Isotretinoin—peripheral nervous system neoplasm	0.00409	0.00413	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Tretinoin—peripheral nervous system neoplasm	0.00409	0.00413	CcSEcCtD
Fludrocortisone—Cardiomegaly—Epirubicin—peripheral nervous system neoplasm	0.00409	0.00413	CcSEcCtD
Fludrocortisone—Neoplasm—Melphalan—peripheral nervous system neoplasm	0.00402	0.00406	CcSEcCtD
Fludrocortisone—Contusion—Alitretinoin—peripheral nervous system neoplasm	0.00391	0.00395	CcSEcCtD
Fludrocortisone—Cardiomegaly—Doxorubicin—peripheral nervous system neoplasm	0.00378	0.00382	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Isotretinoin—peripheral nervous system neoplasm	0.00376	0.0038	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Tretinoin—peripheral nervous system neoplasm	0.00376	0.0038	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Isotretinoin—peripheral nervous system neoplasm	0.0036	0.00364	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Tretinoin—peripheral nervous system neoplasm	0.0036	0.00364	CcSEcCtD
Fludrocortisone—Cataract—Alitretinoin—peripheral nervous system neoplasm	0.00358	0.00362	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Topotecan—peripheral nervous system neoplasm	0.0034	0.00344	CcSEcCtD
Fludrocortisone—Oesophagitis—Dactinomycin—peripheral nervous system neoplasm	0.00336	0.0034	CcSEcCtD
Fludrocortisone—Affect lability—Isotretinoin—peripheral nervous system neoplasm	0.00322	0.00325	CcSEcCtD
Fludrocortisone—Affect lability—Tretinoin—peripheral nervous system neoplasm	0.00322	0.00325	CcSEcCtD
Fludrocortisone—Oesophagitis—Alitretinoin—peripheral nervous system neoplasm	0.00312	0.00315	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Alitretinoin—peripheral nervous system neoplasm	0.0031	0.00313	CcSEcCtD
Fludrocortisone—Mood swings—Tretinoin—peripheral nervous system neoplasm	0.00309	0.00313	CcSEcCtD
Fludrocortisone—Mood swings—Isotretinoin—peripheral nervous system neoplasm	0.00309	0.00313	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Alitretinoin—peripheral nervous system neoplasm	0.00285	0.00288	CcSEcCtD
Fludrocortisone—Abdominal distension—Tretinoin—peripheral nervous system neoplasm	0.00284	0.00287	CcSEcCtD
Fludrocortisone—Abdominal distension—Isotretinoin—peripheral nervous system neoplasm	0.00284	0.00287	CcSEcCtD
Fludrocortisone—Hypernatraemia—Epirubicin—peripheral nervous system neoplasm	0.00284	0.00287	CcSEcCtD
Fludrocortisone—Pancreatitis—Tretinoin—peripheral nervous system neoplasm	0.00277	0.0028	CcSEcCtD
Fludrocortisone—Pancreatitis—Isotretinoin—peripheral nervous system neoplasm	0.00277	0.0028	CcSEcCtD
Fludrocortisone—Fluid retention—Cisplatin—peripheral nervous system neoplasm	0.00276	0.00279	CcSEcCtD
Fludrocortisone—Sweating increased—Tretinoin—peripheral nervous system neoplasm	0.00275	0.00278	CcSEcCtD
Fludrocortisone—Sweating increased—Isotretinoin—peripheral nervous system neoplasm	0.00275	0.00278	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Alitretinoin—peripheral nervous system neoplasm	0.00273	0.00276	CcSEcCtD
Fludrocortisone—Hypernatraemia—Doxorubicin—peripheral nervous system neoplasm	0.00263	0.00265	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Epirubicin—peripheral nervous system neoplasm	0.00251	0.00254	CcSEcCtD
Fludrocortisone—Triamcinolone—BCHE—peripheral nervous system neoplasm	0.00247	0.233	CrCbGaD
Fludrocortisone—Affect lability—Alitretinoin—peripheral nervous system neoplasm	0.00244	0.00246	CcSEcCtD
Fludrocortisone—Oesophagitis—Etoposide—peripheral nervous system neoplasm	0.00243	0.00246	CcSEcCtD
Fludrocortisone—Optic neuritis—Epirubicin—peripheral nervous system neoplasm	0.00243	0.00245	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Etoposide—peripheral nervous system neoplasm	0.00242	0.00245	CcSEcCtD
Fludrocortisone—Mood swings—Alitretinoin—peripheral nervous system neoplasm	0.00235	0.00237	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Cisplatin—peripheral nervous system neoplasm	0.00233	0.00235	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Doxorubicin—peripheral nervous system neoplasm	0.00232	0.00235	CcSEcCtD
Fludrocortisone—Haemoglobin—Topotecan—peripheral nervous system neoplasm	0.00229	0.00231	CcSEcCtD
Fludrocortisone—Haemorrhage—Topotecan—peripheral nervous system neoplasm	0.00228	0.0023	CcSEcCtD
Fludrocortisone—Haemoglobin—Tretinoin—peripheral nervous system neoplasm	0.00227	0.0023	CcSEcCtD
Fludrocortisone—Haemoglobin—Isotretinoin—peripheral nervous system neoplasm	0.00227	0.0023	CcSEcCtD
Fludrocortisone—Haemorrhage—Isotretinoin—peripheral nervous system neoplasm	0.00226	0.00228	CcSEcCtD
Fludrocortisone—Haemorrhage—Tretinoin—peripheral nervous system neoplasm	0.00226	0.00228	CcSEcCtD
Fludrocortisone—Optic neuritis—Doxorubicin—peripheral nervous system neoplasm	0.00224	0.00227	CcSEcCtD
Fludrocortisone—Haemoglobin—Melphalan—peripheral nervous system neoplasm	0.00224	0.00227	CcSEcCtD
Fludrocortisone—Haemorrhage—Melphalan—peripheral nervous system neoplasm	0.00223	0.00225	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Cisplatin—peripheral nervous system neoplasm	0.00218	0.0022	CcSEcCtD
Fludrocortisone—Abdominal distension—Alitretinoin—peripheral nervous system neoplasm	0.00215	0.00218	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Etoposide—peripheral nervous system neoplasm	0.00213	0.00215	CcSEcCtD
Fludrocortisone—Muscular weakness—Vincristine—peripheral nervous system neoplasm	0.0021	0.00213	CcSEcCtD
Fludrocortisone—Pancreatitis—Alitretinoin—peripheral nervous system neoplasm	0.0021	0.00212	CcSEcCtD
Fludrocortisone—Sweating increased—Alitretinoin—peripheral nervous system neoplasm	0.00208	0.00211	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Epirubicin—peripheral nervous system neoplasm	0.00202	0.00204	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Etoposide—peripheral nervous system neoplasm	0.002	0.00202	CcSEcCtD
Fludrocortisone—Erythema—Tretinoin—peripheral nervous system neoplasm	0.00197	0.00199	CcSEcCtD
Fludrocortisone—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.00197	0.00199	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Doxorubicin—peripheral nervous system neoplasm	0.00187	0.00189	CcSEcCtD
Fludrocortisone—Glycosuria—Epirubicin—peripheral nervous system neoplasm	0.00184	0.00186	CcSEcCtD
Fludrocortisone—Petechiae—Epirubicin—peripheral nervous system neoplasm	0.00181	0.00183	CcSEcCtD
Fludrocortisone—Pancreatitis—Cisplatin—peripheral nervous system neoplasm	0.00179	0.00181	CcSEcCtD
Fludrocortisone—Sweating increased—Cisplatin—peripheral nervous system neoplasm	0.00178	0.00179	CcSEcCtD
Fludrocortisone—Haemoglobin—Alitretinoin—peripheral nervous system neoplasm	0.00172	0.00174	CcSEcCtD
Fludrocortisone—Haemorrhage—Alitretinoin—peripheral nervous system neoplasm	0.00171	0.00173	CcSEcCtD
Fludrocortisone—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.0017	0.00172	CcSEcCtD
Fludrocortisone—Convulsion—Tretinoin—peripheral nervous system neoplasm	0.0017	0.00172	CcSEcCtD
Fludrocortisone—Glycosuria—Doxorubicin—peripheral nervous system neoplasm	0.0017	0.00172	CcSEcCtD
Fludrocortisone—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.0017	0.00172	CcSEcCtD
Fludrocortisone—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.0017	0.00172	CcSEcCtD
Fludrocortisone—Amenorrhoea—Epirubicin—peripheral nervous system neoplasm	0.0017	0.00172	CcSEcCtD
Fludrocortisone—Myalgia—Topotecan—peripheral nervous system neoplasm	0.00169	0.00171	CcSEcCtD
Fludrocortisone—Convulsion—Melphalan—peripheral nervous system neoplasm	0.00168	0.0017	CcSEcCtD
Fludrocortisone—Petechiae—Doxorubicin—peripheral nervous system neoplasm	0.00168	0.0017	CcSEcCtD
Fludrocortisone—Myalgia—Tretinoin—peripheral nervous system neoplasm	0.00167	0.00169	CcSEcCtD
Fludrocortisone—Myalgia—Isotretinoin—peripheral nervous system neoplasm	0.00167	0.00169	CcSEcCtD
Fludrocortisone—Myalgia—Melphalan—peripheral nervous system neoplasm	0.00165	0.00167	CcSEcCtD
Fludrocortisone—Sweating increased—Etoposide—peripheral nervous system neoplasm	0.00163	0.00164	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00162	0.00164	CcSEcCtD
Fludrocortisone—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.00161	0.00163	CcSEcCtD
Fludrocortisone—Infection—Topotecan—peripheral nervous system neoplasm	0.00161	0.00163	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00161	0.00162	CcSEcCtD
Fludrocortisone—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.00161	0.00162	CcSEcCtD
Fludrocortisone—Oedema—Tretinoin—peripheral nervous system neoplasm	0.00161	0.00162	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00161	0.00162	CcSEcCtD
Fludrocortisone—Infection—Tretinoin—peripheral nervous system neoplasm	0.00159	0.00161	CcSEcCtD
Fludrocortisone—Infection—Isotretinoin—peripheral nervous system neoplasm	0.00159	0.00161	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00158	0.0016	CcSEcCtD
Fludrocortisone—Oedema—Melphalan—peripheral nervous system neoplasm	0.00158	0.0016	CcSEcCtD
Fludrocortisone—Infection—Melphalan—peripheral nervous system neoplasm	0.00157	0.00159	CcSEcCtD
Fludrocortisone—Amenorrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00157	0.00159	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.00156	0.00158	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.00155	0.00157	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.00155	0.00157	CcSEcCtD
Fludrocortisone—Megestrol acetate—ABCB1—peripheral nervous system neoplasm	0.0015	0.142	CrCbGaD
Fludrocortisone—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.00149	0.00151	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.00147	0.00149	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.00146	0.00148	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00146	0.00148	CcSEcCtD
Fludrocortisone—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.00145	0.00147	CcSEcCtD
Fludrocortisone—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.00145	0.00147	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.00144	0.00146	CcSEcCtD
Fludrocortisone—Fluid retention—Epirubicin—peripheral nervous system neoplasm	0.00142	0.00143	CcSEcCtD
Fludrocortisone—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.00137	0.00138	CcSEcCtD
Fludrocortisone—Oesophagitis—Epirubicin—peripheral nervous system neoplasm	0.00136	0.00138	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Epirubicin—peripheral nervous system neoplasm	0.00136	0.00137	CcSEcCtD
Fludrocortisone—Ecchymosis—Epirubicin—peripheral nervous system neoplasm	0.00135	0.00136	CcSEcCtD
Fludrocortisone—Neoplasm—Epirubicin—peripheral nervous system neoplasm	0.00135	0.00136	CcSEcCtD
Fludrocortisone—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00131	0.00133	CcSEcCtD
Fludrocortisone—Fluid retention—Doxorubicin—peripheral nervous system neoplasm	0.00131	0.00132	CcSEcCtD
Fludrocortisone—Infection—Dactinomycin—peripheral nervous system neoplasm	0.0013	0.00132	CcSEcCtD
Fludrocortisone—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00129	0.00131	CcSEcCtD
Fludrocortisone—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00129	0.0013	CcSEcCtD
Fludrocortisone—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00129	0.0013	CcSEcCtD
Fludrocortisone—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00129	0.0013	CcSEcCtD
Fludrocortisone—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00128	0.00129	CcSEcCtD
Fludrocortisone—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00128	0.00129	CcSEcCtD
Fludrocortisone—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00127	0.00128	CcSEcCtD
Fludrocortisone—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.00127	0.00128	CcSEcCtD
Fludrocortisone—Oesophagitis—Doxorubicin—peripheral nervous system neoplasm	0.00126	0.00128	CcSEcCtD
Fludrocortisone—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00126	0.00127	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Doxorubicin—peripheral nervous system neoplasm	0.00125	0.00127	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Epirubicin—peripheral nervous system neoplasm	0.00125	0.00126	CcSEcCtD
Fludrocortisone—Ecchymosis—Doxorubicin—peripheral nervous system neoplasm	0.00125	0.00126	CcSEcCtD
Fludrocortisone—Neoplasm—Doxorubicin—peripheral nervous system neoplasm	0.00125	0.00126	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Epirubicin—peripheral nervous system neoplasm	0.00125	0.00126	CcSEcCtD
Fludrocortisone—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00124	0.00126	CcSEcCtD
Fludrocortisone—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00124	0.00125	CcSEcCtD
Fludrocortisone—Myalgia—Vincristine—peripheral nervous system neoplasm	0.00122	0.00124	CcSEcCtD
Fludrocortisone—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00122	0.00123	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00122	0.00123	CcSEcCtD
Fludrocortisone—Vascular purpura—Epirubicin—peripheral nervous system neoplasm	0.00121	0.00122	CcSEcCtD
Fludrocortisone—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00121	0.00122	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.0012	0.00121	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Epirubicin—peripheral nervous system neoplasm	0.00119	0.00121	CcSEcCtD
Fludrocortisone—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00119	0.00121	CcSEcCtD
Fludrocortisone—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00118	0.0012	CcSEcCtD
Fludrocortisone—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00118	0.0012	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00119	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00117	0.00119	CcSEcCtD
Fludrocortisone—Oedema—Vincristine—peripheral nervous system neoplasm	0.00117	0.00119	CcSEcCtD
Fludrocortisone—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00117	0.00118	CcSEcCtD
Fludrocortisone—Infection—Vincristine—peripheral nervous system neoplasm	0.00116	0.00118	CcSEcCtD
Fludrocortisone—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00116	0.00117	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Doxorubicin—peripheral nervous system neoplasm	0.00116	0.00117	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.00116	CcSEcCtD
Fludrocortisone—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00115	0.00116	CcSEcCtD
Fludrocortisone—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00115	0.00116	CcSEcCtD
Fludrocortisone—Methylprednisolone—ABCB1—peripheral nervous system neoplasm	0.00115	0.108	CrCbGaD
Fludrocortisone—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00114	0.00115	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00113	0.00115	CcSEcCtD
Fludrocortisone—Purpura—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00114	CcSEcCtD
Fludrocortisone—Vascular purpura—Doxorubicin—peripheral nervous system neoplasm	0.00112	0.00113	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00113	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00111	0.00112	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	0.00111	0.00112	CcSEcCtD
Fludrocortisone—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.0011	0.00111	CcSEcCtD
Fludrocortisone—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.0011	0.00111	CcSEcCtD
Fludrocortisone—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.00108	0.00109	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00107	0.00108	CcSEcCtD
Fludrocortisone—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00108	CcSEcCtD
Fludrocortisone—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00106	0.00107	CcSEcCtD
Fludrocortisone—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00105	0.00106	CcSEcCtD
Fludrocortisone—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00105	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00104	0.00105	CcSEcCtD
Fludrocortisone—Oedema—Cisplatin—peripheral nervous system neoplasm	0.00104	0.00105	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00105	CcSEcCtD
Fludrocortisone—Infection—Cisplatin—peripheral nervous system neoplasm	0.00103	0.00104	CcSEcCtD
Fludrocortisone—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00104	CcSEcCtD
Fludrocortisone—Headache—Topotecan—peripheral nervous system neoplasm	0.00101	0.00102	CcSEcCtD
Fludrocortisone—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00101	0.00102	CcSEcCtD
Fludrocortisone—Headache—Tretinoin—peripheral nervous system neoplasm	0.00101	0.00102	CcSEcCtD
Fludrocortisone—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00101	0.00102	CcSEcCtD
Fludrocortisone—Hypertension—Etoposide—peripheral nervous system neoplasm	0.001	0.00102	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.001	0.00101	CcSEcCtD
Fludrocortisone—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000987	0.000997	CcSEcCtD
Fludrocortisone—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000967	0.000977	CcSEcCtD
Fludrocortisone—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000967	0.000977	CcSEcCtD
Fludrocortisone—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000955	0.000966	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00095	0.00096	CcSEcCtD
Fludrocortisone—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000949	0.00096	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000945	0.000955	CcSEcCtD
Fludrocortisone—Infection—Etoposide—peripheral nervous system neoplasm	0.000944	0.000954	CcSEcCtD
Fludrocortisone—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000942	0.000953	CcSEcCtD
Fludrocortisone—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000942	0.000952	CcSEcCtD
Fludrocortisone—Spironolactone—ABCB1—peripheral nervous system neoplasm	0.000933	0.088	CrCbGaD
Fludrocortisone—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000918	0.000928	CcSEcCtD
Fludrocortisone—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000918	0.000928	CcSEcCtD
Fludrocortisone—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000896	0.000906	CcSEcCtD
Fludrocortisone—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000884	0.000893	CcSEcCtD
Fludrocortisone—Prednisone—ABCB1—peripheral nervous system neoplasm	0.000879	0.0829	CrCbGaD
Fludrocortisone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000873	0.000882	CcSEcCtD
Fludrocortisone—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000872	0.000881	CcSEcCtD
Fludrocortisone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000864	0.000873	CcSEcCtD
Fludrocortisone—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000849	0.000858	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000845	0.000854	CcSEcCtD
Fludrocortisone—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000841	0.00085	CcSEcCtD
Fludrocortisone—Prednisolone—ABCB1—peripheral nervous system neoplasm	0.00081	0.0764	CrCbGaD
Fludrocortisone—Betamethasone—ABCB1—peripheral nervous system neoplasm	0.000794	0.0749	CrCbGaD
Fludrocortisone—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000781	0.00079	CcSEcCtD
Fludrocortisone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000764	0.000772	CcSEcCtD
Fludrocortisone—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000762	0.00077	CcSEcCtD
Fludrocortisone—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000755	0.000763	CcSEcCtD
Fludrocortisone—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000753	0.000761	CcSEcCtD
Fludrocortisone—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000749	0.000757	CcSEcCtD
Fludrocortisone—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000744	0.000752	CcSEcCtD
Fludrocortisone—Headache—Vincristine—peripheral nervous system neoplasm	0.000734	0.000742	CcSEcCtD
Fludrocortisone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.0007	0.000707	CcSEcCtD
Fludrocortisone—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000697	0.000704	CcSEcCtD
Fludrocortisone—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000693	0.000701	CcSEcCtD
Fludrocortisone—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000681	0.000689	CcSEcCtD
Fludrocortisone—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000652	0.000659	CcSEcCtD
Fludrocortisone—Hydrocortisone—ABCB1—peripheral nervous system neoplasm	0.00062	0.0585	CrCbGaD
Fludrocortisone—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000604	0.00061	CcSEcCtD
Fludrocortisone—Headache—Etoposide—peripheral nervous system neoplasm	0.000595	0.000601	CcSEcCtD
Fludrocortisone—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000586	0.000592	CcSEcCtD
Fludrocortisone—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000565	0.000571	CcSEcCtD
Fludrocortisone—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000563	0.000569	CcSEcCtD
Fludrocortisone—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000555	0.000561	CcSEcCtD
Fludrocortisone—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000542	0.000548	CcSEcCtD
Fludrocortisone—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000532	0.000538	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000532	0.000538	CcSEcCtD
Fludrocortisone—Infection—Epirubicin—peripheral nervous system neoplasm	0.000529	0.000535	CcSEcCtD
Fludrocortisone—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000523	0.000529	CcSEcCtD
Fludrocortisone—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000521	0.000527	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000515	0.00052	CcSEcCtD
Fludrocortisone—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000514	0.000519	CcSEcCtD
Fludrocortisone—Progesterone—ABCB1—peripheral nervous system neoplasm	0.000505	0.0476	CrCbGaD
Fludrocortisone—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000493	0.000498	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000493	0.000498	CcSEcCtD
Fludrocortisone—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000489	0.000495	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000485	0.00049	CcSEcCtD
Fludrocortisone—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000482	0.000487	CcSEcCtD
Fludrocortisone—Testosterone—ABCB1—peripheral nervous system neoplasm	0.000477	0.045	CrCbGaD
Fludrocortisone—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000476	0.000481	CcSEcCtD
Fludrocortisone—Dexamethasone—ABCB1—peripheral nervous system neoplasm	0.000462	0.0436	CrCbGaD
Fludrocortisone—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000449	0.000454	CcSEcCtD
Fludrocortisone—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000446	0.00045	CcSEcCtD
Fludrocortisone—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000423	0.000427	CcSEcCtD
Fludrocortisone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000392	0.000396	CcSEcCtD
Fludrocortisone—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000391	0.000396	CcSEcCtD
Fludrocortisone—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000382	0.000386	CcSEcCtD
Fludrocortisone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000367	CcSEcCtD
Fludrocortisone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000353	0.000357	CcSEcCtD
Fludrocortisone—Headache—Epirubicin—peripheral nervous system neoplasm	0.000334	0.000337	CcSEcCtD
Fludrocortisone—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000309	0.000312	CcSEcCtD
